JP2016525507A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016525507A5 JP2016525507A5 JP2016524315A JP2016524315A JP2016525507A5 JP 2016525507 A5 JP2016525507 A5 JP 2016525507A5 JP 2016524315 A JP2016524315 A JP 2016524315A JP 2016524315 A JP2016524315 A JP 2016524315A JP 2016525507 A5 JP2016525507 A5 JP 2016525507A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- oligosaccharide
- protein
- subject
- rha
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361842474P | 2013-07-03 | 2013-07-03 | |
| US61/842,474 | 2013-07-03 | ||
| PCT/US2014/045057 WO2015002954A1 (en) | 2013-07-03 | 2014-07-01 | Synthetic oligosaccharides for p. aeruginosa vaccine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2016525507A JP2016525507A (ja) | 2016-08-25 |
| JP2016525507A5 true JP2016525507A5 (https=) | 2017-08-10 |
Family
ID=52144159
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016524315A Pending JP2016525507A (ja) | 2013-07-03 | 2014-07-01 | 緑膿菌ワクチンのための合成オリゴ糖 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20160144016A1 (https=) |
| EP (1) | EP3016685B1 (https=) |
| JP (1) | JP2016525507A (https=) |
| KR (1) | KR20160098161A (https=) |
| CN (1) | CN105517573A (https=) |
| AU (1) | AU2014284457A1 (https=) |
| CA (1) | CA2917192A1 (https=) |
| CL (1) | CL2015003792A1 (https=) |
| HK (1) | HK1217642A1 (https=) |
| IL (1) | IL243432A0 (https=) |
| MX (1) | MX2016000195A (https=) |
| SG (1) | SG11201510792XA (https=) |
| WO (1) | WO2015002954A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20170105107A (ko) * | 2015-02-26 | 2017-09-18 | 더백스 제네틱스 백신 코포레이션, 엘티디. | 항원-특이적인 t-세포 반응을 도출하는 데 사용하기 위한 면역원성 단백질 및 조합 아주반트를 포함하는 백신 조성물 |
| CN110423273B (zh) * | 2017-11-01 | 2022-03-11 | 深圳市国创纳米抗体技术有限公司 | 抗绿脓杆菌外毒素a纳米抗体及其应用 |
| CA3160266A1 (en) * | 2019-12-04 | 2021-06-10 | University Of Montana | Antibacterial carbohydrate vaccine |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4693891A (en) * | 1985-09-09 | 1987-09-15 | Miles Laboratories, Inc. | Vaccine for Pseudomonas aeruginosa |
| EP1479695B1 (en) * | 2003-05-14 | 2010-02-17 | Kenta Biotech AG | Human monoclonal antibody specific for lipopolysaccharides (LPS) of serotype IATS O6 of Pseudomonas aeruginosa |
| CN101912609B (zh) * | 2009-08-20 | 2012-02-01 | 成都蓉生药业有限责任公司 | 防治绿脓杆菌感染的组合物及其制备方法 |
| CA2797052A1 (en) * | 2010-04-23 | 2011-10-27 | Ancora Pharmaceuticals Inc. | Synthetic oligosaccharides for staphyloccocus vaccine |
| CN101947323B (zh) * | 2010-07-26 | 2013-02-27 | 北京绿竹生物制药有限公司 | 一种革兰氏阴性细菌疫苗及其制备方法 |
| WO2012082635A1 (en) * | 2010-12-13 | 2012-06-21 | Ancora Pharmaceuticals, Inc. | Synthetic oligosaccharide group a streptococcus |
| EP2554549A1 (en) * | 2011-08-02 | 2013-02-06 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Oligosaccharides and oligosaccharides-protein conjugates derived from clostridium difficile polysaccharide PS-I, methods of synthesis and uses thereof, in particular as vaccines and diagnostic tools |
| JP2015525771A (ja) * | 2012-07-16 | 2015-09-07 | シングリコ、インコーポレイテッド | 緑膿菌ワクチンのための合成オリゴ糖 |
-
2014
- 2014-07-01 WO PCT/US2014/045057 patent/WO2015002954A1/en not_active Ceased
- 2014-07-01 KR KR1020167001973A patent/KR20160098161A/ko not_active Withdrawn
- 2014-07-01 EP EP14820560.2A patent/EP3016685B1/en not_active Not-in-force
- 2014-07-01 SG SG11201510792XA patent/SG11201510792XA/en unknown
- 2014-07-01 JP JP2016524315A patent/JP2016525507A/ja active Pending
- 2014-07-01 AU AU2014284457A patent/AU2014284457A1/en not_active Abandoned
- 2014-07-01 HK HK16105605.8A patent/HK1217642A1/zh unknown
- 2014-07-01 CN CN201480048550.9A patent/CN105517573A/zh active Pending
- 2014-07-01 US US14/902,218 patent/US20160144016A1/en not_active Abandoned
- 2014-07-01 CA CA2917192A patent/CA2917192A1/en not_active Abandoned
- 2014-07-01 MX MX2016000195A patent/MX2016000195A/es unknown
-
2015
- 2015-12-30 CL CL2015003792A patent/CL2015003792A1/es unknown
- 2015-12-31 IL IL243432A patent/IL243432A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI425951B (zh) | 共軛方法 | |
| AU2018243910B2 (en) | A multiple antigen presenting system (MAPS)-based staphylococcus aureus vaccine, immunogenic composition, and uses thereof | |
| JP2011042693A5 (https=) | ||
| US20090226469A1 (en) | Shiga Toxoid Chimeric Proteins | |
| CA3170344A1 (en) | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof | |
| AU2010264538A1 (en) | Immunogenic compositions of Staphylococcus aureus antigens | |
| CA3005524A1 (en) | Immunogenic compositions for use in pneumococcal vaccines | |
| JP6773830B2 (ja) | 治療において使用するための免疫原性組成物 | |
| KR102077876B1 (ko) | Ｃｒｍ１９７ 담체 단백질에 커플링된 ｈｉｖ ｇｐ４１ 펩티드를 포함하는 면역원성 화합물 | |
| JP2016525507A5 (https=) | ||
| EP4489776A2 (en) | A multiple antigen presenting system (maps)-based staphylococcus aureus vaccine comprising b- and t-cell antigens, immunogenic composition, and uses thereof | |
| JP2015525771A5 (https=) | ||
| JPWO2018074296A1 (ja) | 低分子化ＰＲＰを用いたＨｉｂコンジュゲートワクチンの製造方法 | |
| JP2009521434A (ja) | 髄膜炎菌由来の誘導体化多糖類−タンパク質の多価コンジュゲートおよびワクチン | |
| US20150152129A1 (en) | Synthetic Oligosaccharides for P. Aeruginosa Vaccine | |
| RU2791256C2 (ru) | Иммуногенные композиции | |
| AU2015359503B2 (en) | Method of treatment | |
| JP2025535293A (ja) | ワクチン | |
| Messner et al. | Zina Mosleh* and Frank M. Unger |